Last reviewed · How we verify
NCT05403736: CARMA
Cardiac Aggressive Risk Mitigation in Thoracic Radiotherapy (CARMA) Trial
NA trial testing Cardiac Aggressive Risk MitigAtion Plan in Cancer in 20 participants. Completed in 16 June 2023.
16 June 2023
Quick facts
| Lead sponsor | Cedars-Sinai Medical Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 20 |
| Start date | 7 October 2022 |
| Primary completion | 16 June 2023 |
| Estimated completion | 16 June 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Cardiac Aggressive Risk MitigAtion Plan
Conditions studied
- Cancer — all drugs for Cancer →
Sponsor
Cedars-Sinai Medical Center
Who can join
18 and older, any sex, with Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to examine adherence to cardio-oncology consultation.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Cardiotoxicity following thoracic radiotherapy for lung cancer.
Walls GM, Bergom C, Mitchell JD, Rentschler SL, et al · · 2025 · cited 21× · PMID 39506136 · DOI 10.1038/s41416-024-02888-0 -
Early cardio-oncology intervention in thoracic radiotherapy: prospective single-arm pilot study.
Zhang SC, Gasho JO, Eno C, Silos KD, et al · · 2025 · cited 2× · PMID 39962137 · DOI 10.1038/s43856-025-00761-6
Verify or expand the search:
- PubMed search for NCT05403736
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cancer
Currently open trials in the same condition.
- NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
- NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
- NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
- NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
- NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting
Other Cedars-Sinai Medical Center trials
Trials by the same sponsor.
- NCT06012487 — Correlates and Control of Blood Pressure Variability · Phase 1 · not yet recruiting
- NCT07495995 — SAMe for Prevention of Liver Cancer in MASLD-Related Cirrhosis · Phase 2 · not yet recruiting
- NCT07413965 — TAVR vs SAVR in Severe Bicuspid Aortic Stenosis · NA · not yet recruiting
- NCT06521021 — CHOICE to AVOID or RESIST · NA · not yet recruiting
- NCT07499089 — Together-Breast Cancer Support Platform · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05403736 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cedars-Sinai Medical Center
- Last refreshed: 6 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05403736.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing